1. Home
  2. CBUS vs HSIC Comparison

CBUS vs HSIC Comparison

Compare CBUS & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBUS
  • HSIC
  • Stock Information
  • Founded
  • CBUS 2010
  • HSIC 1932
  • Country
  • CBUS United States
  • HSIC United States
  • Employees
  • CBUS N/A
  • HSIC N/A
  • Industry
  • CBUS Agricultural Chemicals
  • HSIC Medical Specialities
  • Sector
  • CBUS Industrials
  • HSIC Health Care
  • Exchange
  • CBUS Nasdaq
  • HSIC Nasdaq
  • Market Cap
  • CBUS 65.3M
  • HSIC 8.1B
  • IPO Year
  • CBUS 2017
  • HSIC 1995
  • Fundamental
  • Price
  • CBUS $2.35
  • HSIC $68.89
  • Analyst Decision
  • CBUS Strong Buy
  • HSIC Buy
  • Analyst Count
  • CBUS 3
  • HSIC 10
  • Target Price
  • CBUS $22.17
  • HSIC $79.30
  • AVG Volume (30 Days)
  • CBUS 130.4K
  • HSIC 1.3M
  • Earning Date
  • CBUS 05-08-2025
  • HSIC 05-05-2025
  • Dividend Yield
  • CBUS N/A
  • HSIC N/A
  • EPS Growth
  • CBUS N/A
  • HSIC 8.11
  • EPS
  • CBUS N/A
  • HSIC 3.21
  • Revenue
  • CBUS $4,262,000.00
  • HSIC $12,669,000,000.00
  • Revenue This Year
  • CBUS $105.58
  • HSIC $4.73
  • Revenue Next Year
  • CBUS $194.76
  • HSIC $3.62
  • P/E Ratio
  • CBUS N/A
  • HSIC $21.46
  • Revenue Growth
  • CBUS 134.56
  • HSIC 1.75
  • 52 Week Low
  • CBUS $1.40
  • HSIC $60.56
  • 52 Week High
  • CBUS $19.56
  • HSIC $82.49
  • Technical
  • Relative Strength Index (RSI)
  • CBUS 59.91
  • HSIC 58.53
  • Support Level
  • CBUS $1.96
  • HSIC $65.86
  • Resistance Level
  • CBUS $2.58
  • HSIC $66.59
  • Average True Range (ATR)
  • CBUS 0.24
  • HSIC 1.96
  • MACD
  • CBUS 0.06
  • HSIC 0.60
  • Stochastic Oscillator
  • CBUS 73.86
  • HSIC 93.11

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

Share on Social Networks: